Osteomyelitis of the femur caused by Metamycoplasma orale in an immunocompromised patient using metagenomic next-generation sequencing: A case report
- PMID: 38586336
- PMCID: PMC10998140
- DOI: 10.1016/j.heliyon.2024.e28730
Osteomyelitis of the femur caused by Metamycoplasma orale in an immunocompromised patient using metagenomic next-generation sequencing: A case report
Abstract
Background: Metamycoplasma orale (M.orale), a symbiotic bacterium observed in the human oral cavity, is generally regarded as non-pathogenic to humans. Although infrequent, symptomatic infections caused by M.orale may occur in individuals with compromised humoral immunity. Accurate identification and early diagnosis of M.orale still present significant challenges due the limitations associated with conventional detection methods. Although metagenomic next-generation sequencing (mNGS) is currently widely utilized in clinical practices and exhibits a remarkable specificity and sensitivity for detecting various pathogens, its application in the diagnosis of M.orale-induced osteomyelitis remains largely unexplored.
Case description: In this report, we present a case study of osteonecrosis caused by M.orale in a 20-year-old female patient with nephrotic syndrome and other comorbidities. She was administered long-term hormone therapy and immunosuppressants, leading to her admission to the hospital due to recurrent fever, hip abscess and left thigh pain. Imaging examination revealed bilateral mid-femoral lesions, with the extensive nature of the left femoral lesion suggesting a potential secondary infection. Although no pathogen was detected in pus culture, mNGS analysis identified M.orale in the sample. Following treatment with doxycycline and levofloxacin, the patient's symotoms improved and she was discharged with favorable outcomes.
Conclusion: mNGS enables rapid identification of etiology in patients with osteomyelitis caused by the rare pathogen M.orale. This case accentuate the strength of mNGS for early detection and targeted clinical treatment of infectious diseases caused by uncommon pathogens.
Keywords: Case report; Immunocompromise; Metagenomic next generation sequencing; Metamycoplasma orale; Osteomyelitis.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Case report: A toxoplasmic encephalitis in an immunocompromised child detected through metagenomic next-generation sequencing.Front Public Health. 2023 Sep 28;11:1247233. doi: 10.3389/fpubh.2023.1247233. eCollection 2023. Front Public Health. 2023. PMID: 37841727 Free PMC article.
-
Case report: Metagenomic next-generation sequencing for the diagnosis of rare Nocardia aobensis infection in a patient with immune thrombocytopenia.Front Med (Lausanne). 2024 Nov 6;11:1425655. doi: 10.3389/fmed.2024.1425655. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39568747 Free PMC article.
-
The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis.Front Cell Infect Microbiol. 2023 Jan 27;13:1106097. doi: 10.3389/fcimb.2023.1106097. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36779189 Free PMC article.
-
Rapid diagnosis of Talaromyces marneffei infection by metagenomic next-generation sequencing technology in a Chinese cohort of inborn errors of immunity.Front Cell Infect Microbiol. 2022 Sep 8;12:987692. doi: 10.3389/fcimb.2022.987692. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36159645 Free PMC article.
-
The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review.Expert Rev Mol Diagn. 2022 May;22(5):575-582. doi: 10.1080/14737159.2022.2071607. Epub 2022 May 2. Expert Rev Mol Diagn. 2022. PMID: 35473493 Review.
References
-
- Totten A.H., Uzel G., Khil P.P., Youn J.H., Treat J., Soutar C.D., Holland S.M., Dekker J.P., Zerbe C.S. Disseminated mycoplasma orale infection in patients with phosphoinositide-3-kinase regulatory subunit 1 mutations. Open Forum Infect. Dis. 2022;9(9) doi: 10.1093/ofid/ofac472. - DOI - PMC - PubMed
-
- Gómez Rufo D., García Sánchez E., García Sánchez J.E., García Moro M. Implicaciones clínicas de las especies del género Mycoplasma [Clinical implications of the genus Mycoplasma] Rev. Española Quimioter. : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2021;34(3):169–184. doi: 10.37201/req/014.2021. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources